HUTCHMED (LON:HCM) Stock Price Crosses Below 200-Day Moving Average – Should You Sell?

HUTCHMED (China) Limited (LON:HCM)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 221.21 and traded as low as GBX 204. HUTCHMED shares last traded at GBX 204, with a volume of 15,180 shares.

HUTCHMED Stock Performance

The stock has a market capitalization of £1.75 billion, a P/E ratio of 3.85 and a beta of 0.51. The company has a quick ratio of 2.97, a current ratio of 4.96 and a debt-to-equity ratio of 7.91. The business has a fifty day moving average price of GBX 217.75 and a 200-day moving average price of GBX 221.21.

HUTCHMED Company Profile

We are among the first global-focused novel drug discovery companies in China. Over the past two decades, we have established a fully integrated R&D platform with world-class discovery and development capabilities. Since inception, we have focused on bringing cancer drug candidates from in-house discovery to patients around the world, with our first three oncology medicines now approved marketed in China, the first of which is also marketed in the U.S.

We have also developed a profitable commercial platform with deep pan-China market access, which manufactures, markets and distributes our novel oncology products, as well as prescription drugs and consumer health products in China.

HUTCHMED is listed on the Nasdaq Global Select Market, the Stock Exchange of Hong Kong Limited and the London Stock Exchange’s AIM market (Nasdaq/AIM:HCM; HKEX:13).